TransMedics Group, Inc. (BIT:1TMDX)

Market Cap	4.00B +105.0%
Revenue (ttm)	482.70M +41.2%
Net Income	78.21M +181.2%
EPS	2.16 +170.7%
Shares Out	n/a
PE Ratio	51.14
Forward PE	50.45
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	6
Open	n/a
Previous Close	115.25
Day's Range	n/a
52-Week Range	78.74 - 129.65
Beta	n/a
RSI	50.45
Earnings Date	Feb 24, 2026

About TransMedics Group

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung trans...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1998
• Employees: 728
• Stock Exchange: Borsa Italiana
• Ticker Symbol: 1TMDX

Financial Performance

Financial numbers in USD